Compare
Quest Diagnostics vs Labcorp (DGX vs LH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Quest Diagnostics (DGX) returned +43.4% and Labcorp (LH) +46.2%; so far this year the figures are +47.3% and +46.1%.
Labcorp is the larger company by market value, though the two are close in size.
On trailing earnings, DGX trades at 25.5 times and LH at 30.1 times.
Revenue grew +9.1% at DGX and +6.0% at LH over the last year.
DGX yields 1.32%. LH yields 0.79%.
Data as of the latest close. Not investment advice.
Relative performance
| DGX | LH | |
|---|---|---|
| Price | $255.63 | $366.57 |
| 1-day | +0.35% | +0.90% |
| YTD | +47.31% | +46.11% |
| 1 year | +43.40% | +46.22% |
| 3 years | +92.88% | +79.74% |
| Market cap | $28.1B | $29.8B |
| P/E | 25.5 | 30.1 |
| P/S | 2.38 | 2.04 |
| P/B | 3.69 | 3.36 |
| Revenue growth | +9.10% | +6.00% |
| EPS growth | +17.80% | +19.60% |
| Gross margin % | 33.1 | 29.0 |
| Net margin % | 9.5 | 6.9 |
| ROE % | 14.8 | 11.3 |
| Debt / equity | 0.73 | 0.66 |
| FCF yield % | 4.9 | 4.3 |
| Dividend yield % | 1.32 | 0.79 |
| Beta | -0.05 | 0.38 |
| RSI (14) | 66.9 | 69.9 |
| Technical rating |